Warrior CARE: Cannabis Behavioral Health
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- Wayne State University
- Study ID
- NCT06381180
- Phase
- PHASE1/PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cannabis Use
- Marijuana
- Post Traumatic Stress Disorder
- Suicide
- Veterans
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - 69 Years
- Healthy Volunteers
- Not accepted
Interventions
- Tetrahydrocannabinol — DRUGPlant cannabis that will be smoked
- Cannabidiol — DRUGPlant cannabidiol that will be smoked
- Placebo — DRUGPlant will be smoked.
Study Details
This study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.
Key Dates
- Start date
- Sep 22, 2025
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: THC GroupCannabis with 5 mg THC; up to a maximum of 5 doses/day (max dose = 25 mg THC)
- Experimental: CBD GroupCannabis with 5 mg CBD; up to a maximum of 5 doses/day (max dose = 25 mg CBD)
- Experimental: THC & CBD GroupCannabis with 5 mg THC and 5 mg CBD; up to a maximum of 5 doses/day (max doses = 25 mg THC and 25 mg CBD)
- Active Comparator: Placebo GroupCannabis with \<1mg THC and \<1mg CBD; up to a maximum of 5 doses/day (max dose = \<5 mg THC and \<5 mg CBD)
Primary Outcome Measure
Assessing change in PTSD diagnosis and its symptom severity from pre-treatment to post-treatment using the CAPS-5 assessment. [ Time Frame: Administered at a pre-treatment visit (at the initial screening visit); and at the four post-treatment visits (one week post-treatment and 3-, 6-, and 9-months post-treatment visits). ]
Central Contacts
- Leslie Lundahl, PhD3139931374
- Paula Qefaliaj, B.S.2487168321
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wayne State University | Detroit | Michigan | 48201 | Nareen Sadik, B.S. |
Find similar trials in Detroit, MI
Related Studies
- Testing the Efficacy of ACT for LifeEnrolling By Invitation · VA Office of Research and Development · Aurora, Colorado
- Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care WorkersRecruiting · University of Michigan · San Diego, California
- Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & RecoveryPHASE1 · Not Yet Recruiting · Wayne State University · Detroit, Michigan
- Text-based Support for Parents of Adolescents Following an Emergency Department VisitsRecruiting · University of Michigan · Ann Arbor, Michigan